Alois B. Lang
Corporate Officer/Principal en University of Bern .
Cargos activos de Alois B. Lang
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| University of Bern | Corporate Officer/Principal | - | - |
Historial de carrera de Alois B. Lang
Antiguos cargos conocidos de Alois B. Lang.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| GENEURO SA | Corporate Officer/Principal | - | 31/12/2018 |
Kenta Biotech AG
 Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Director Técnico/Científico/I+D | 02/09/2006 | - |
| Fundador | 02/09/2006 | - |
Formación de Alois B. Lang.
| Swiss Federal Institute of Technology | Doctorate Degree |
Estadísticas
Internacional
| Suiza | 5 |
Operativa
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GENEURO SA | Health Technology |
| Empresas privadas | 1 |
|---|---|
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Alois B. Lang
- Experiencia
